Ophthalmic Drugs Market To Achieve A 6% CAGR In The Forecast Period By 2023Posted by Nita on November 15th, 2019 Ophthalmic Drugs Market – Overview Ophthalmic Drugs Market Research Report - Global Forecast till 2025 The changes in lifestyle and environment have raised the incidence of eye disorders that require medicines to treat the situation. Reports that gauge the medical device industry have been made available by Market Research Future which creates reports on several industry verticals that review the market growth and prospects. The market is on course to achieve a CAGR of 6 % in the approaching forecast period. The influence of factors such as increasing awareness of eye disease and increased research funding in ophthalmology is expected to motivate the ophthalmic drugs market in the coming years. The increased level of research into drugs for ophthalmic application is greatly inspiring the market for ophthalmic drugs in the forecast period. Moreover, the increased aging population is predicted to create additional opportunities for development in the approaching period. Segmental Analysis The segmentation of the ophthalmic drugs market is carried out on the basis of drug class, product, indication, type of dosage, and distribution channel. Based on indication, the ophthalmic drugs market is segmented into retinal disorders, inflammation/infection, glaucoma, dry eye, uveitis, allergies, and others. The segmentation of the market for ophthalmic drugs based on drug class comprises of antiglaucoma, anti-inflammatory, antiallergy, anti-VEGF agents, and others. The anti-inflammatory segment is additionally segmented into steroidal drugs and nonsteroidal drugs. Based on the dosage, the ophthalmic drugs market is segmented into ointments, eye drops, capsules and tablets, eye solutions, and gels. By product, the ophthalmic drugs market is segmented into OTC drugs and prescription drugs. Based on the distribution channel, the ophthalmic drugs market is segmented into online pharmacies, drug stores, hospital pharmacies, and others. demand, and expansion of healthcare technology globally. Moreover, the Middle East and Africa region control the minimum share of the ophthalmic drugs market owing to low growth, deficiency of technical knowledge, and deprived medical facilities. Competitive Analysis The central players featured in the ophthalmic drugs market are Allergan Plc, Bausch & Lomb Inc., Genentech, Inc., Merck & Co., Inc., Pfizer Inc., Actavis Generics, Regeneron Pharmaceuticals, Inc., Shire Plc, Sun Pharmaceutical Industries Limited, Santen Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International, Inc., and others. Global Ophthalmic Drugs Market Research Report: Information by Dosage Form (Eye Drops, Eye Ointments, Eye Solutions, Gels, Capsules & Tablets and others), Product Type (Prescription Drug and OTC Drug), Drug Class (Antibiotics, Anti-Inflammatory, Anti-Glaucoma and others), Indication (Glaucoma, Retinal Disorder, Dry Eye, Eye Allergy and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025 : https://www.marketresearchfuture.com/reports/ophthalmic-drugs-market-5753 Like it? Share it!More by this author |